Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On

The trial studied the efficacy of bamlanivimab in combination with the antiviral remdesivir on Hospitalized Covid-19 patients. Researchers concluded the antibody treatment was "unlikely to help."

(Image credit: David Morrison/AP)



This post first appeared on NPR : National Public Radio : News & Analysis, Wor, please read the originial post: here

Share the post

Eli Lilly Ends Antibody Trial In Hospitalized COVID-19 Patients, Other Trials Go On

×

Subscribe to Npr : National Public Radio : News & Analysis, Wor

Get updates delivered right to your inbox!

Thank you for your subscription

×